Ticagrelor
Generic Name: Ticagrelor
Uses & Medical Indications
To reduce the rate of cardiovascular death, MI, and stroke in patients with acute coronary syndrome (ACS) or a history of MI
Acute Coronary Syndrome, History of Myocardial Infarction
Work Mechanism & Pharmacology
Patient Overview of Work Mechanism
Ticagrelor works at the cellular level to correct underlying biochemical imbalances, reduce clinical symptoms, and support overall health.
Clinical Mechanism of Action (MoA)
Ticagrelor exerts targeted therapeutic activity by interacting with specific cellular receptors, enzymatic pathways, or biological signaling cascades to relieve symptoms and restore physiological balance.
Dosage & Administration Guidelines
180 mg loading dose, then 90 mg twice daily for 1 year, then 60 mg twice daily
Not established
No dosage adjustment needed
90 mg twice daily
No adjustment necessary
Avoid in severe hepatic impairment
Side Effects & Safety Warnings
Bleeding, dyspnea
Major bleeding, intracranial hemorrhage, bradycardia
History of intracranial hemorrhage, active pathological bleeding
Aspirin maintenance dose should not exceed 100 mg/day
Interactions (Drugs, Food & Alcohol)
Strong CYP3A4 inhibitors and inducers, aspirin > 100mg
Grapefruit juice may increase levels
Avoid excessive use (increased bleeding risk)
Pregnancy & Breastfeeding Safety
Use only if benefit justifies risk
Not recommended
Patient Counseling & Practical Advice
Do not take more than 100mg of aspirin daily. Report any unusual bleeding. May cause shortness of breath.
Skip the missed dose and take the next dose at the scheduled time.
Signs of bleeding, dyspnea, hemoglobin
When to Seek Urgent Medical Attention
Seek immediate emergency medical care (call emergency services or proceed to the nearest emergency department) if you experience signs of a life-threatening allergic reaction (anaphylaxis: facial, lip, tongue, or throat swelling causing airway obstruction), severe cutaneous blistering with skin peeling, sudden intense chest pain, or symptoms of overdose.
Content for Ticagrelor was synthesized from standardized public health monographs, official pharmacopoeias, and health authorities:
- Central Drugs Standard Control Organization (CDSCO) — National List of Essential Medicines
- World Health Organization (WHO) — Model List of Essential Medicines
- Indian Pharmacopoeia Commission (IPC) — Indian Pharmacopoeia Drug Monographs
- National Health Service (NHS) — Medicines A to Z Clinical Guidelines
The information provided on this website is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition.